Eluxadoline | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Eluxadoline
Health Canada Patents

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

Contact Supplier

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Contact Supplier

medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.

Contact Supplier

Coral

Contact Supplier

ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

Contact Supplier

Eluxadoline

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

12 API Suppliers, 5 USDMF, 2 EU WC, 4 NDC API, 9 Listed Suppliers, $ API Reference Price

12 API Suppliers
5 USDMF
2 EU WC
4 NDC API
9 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

10 Drugs in Development

10 Drugs in Development

INTERMEDIATES

15 Intermediate Suppliers

15 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

12 FDF Dossiers, 8 FDA Orange Book, 2 Europe, 2 Canada

12 FDF Dossiers
8 FDA Orange Book
2 Europe
2 Canada

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 14 SPI Pharma, 3 DKSH, 3 Gangwal Healthcare, 1 Pfanstiehl, 3 Actylis, 1 Aeon Procare, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 5 Corel Pharma Chem, 2 DFE Pharma, 1 Esteem Industries, 1 Finar, 7 Gangwal Chemicals, 2 Ideal Cures, 1 Ingredion Pharma Solutions, 5 Kerry, 1 Keval Exports, 9 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 12 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Silverline Chemicals, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

36 Fillers, Diluents & Binders, 19 Coating Systems & Additives, 17 Direct Compression, 14 Chewable & Orodispersible Aids, 14 Thickeners and Stabilizers, 12 Taste Masking, 12 Controlled & Modified Release, 12 Lubricants & Glidants, 9 Topical, 9 Co-Processed Excipients, 9 Disintegrants & Superdisintegrants, 9 Granulation, 5 Solubilizers, 5 Parenteral, 4 Film Formers & Plasticizers, 3 Emulsifying Agents, 2 Coloring Agents, 2 API Stability Enhancers, 1 Rheology Modifiers

36 Fillers, Diluents & Binders
19 Coating Systems & Additives
17 Direct Compression
14 Chewable & Orodispersible Aids
14 Thickeners and Stabilizers
12 Taste Masking
12 Controlled & Modified Release
12 Lubricants & Glidants
9 Topical
9 Co-Processed Excipients
9 Disintegrants & Superdisintegrants
9 Granulation
5 Solubilizers
5 Parenteral
4 Film Formers & Plasticizers
3 Emulsifying Agents
2 Coloring Agents
2 API Stability Enhancers
1 Rheology Modifiers

DIGITAL CONTENT

22 News #PharmaBuzz

22 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 4 Annual Reports

1 US Medicaid Prescriptions
4 Annual Reports

MARKET PLACE

5 APIs

5 APIs

PATENTS & EXCLUSIVITIES

42 US Patents, 4 Health Canada Patents

42 US Patents
4 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ API Ref.Price (USD/KG) : 6,058 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 4AbbVie Corporation

filter Patent Reset all filters

4 All

01 22560047

02 22695126

filter Product Reset all filters

4 All

01 4ELUXADOLINE

filter Dosage Reset all filters

4 All

01 4TABLET

filter Exp Date Reset all filters

4 All

01 22025-03-14

02 22028-07-07

Product Main Page

01

AbbVie Corporation

ELUXADOLINE

Formnext Forum

Not Confirmed

AbbVie Corporation

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-03-14

Date Granted : 2013-12-24

ELUXADOLINE

Brand Name : VIBERZI

Patent Number : 2560047

Filing Date : 2005-03-14

Strength per Unit : 75 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-03-14

Date Granted : 2013-12-24

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

AbbVie Corporation

ELUXADOLINE

Formnext Forum

Not Confirmed

AbbVie Corporation

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-07-07

Date Granted : 2018-10-30

ELUXADOLINE

Brand Name : VIBERZI

Patent Number : 2695126

Filing Date : 2008-07-07

Strength per Unit : 75 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-07-07

Date Granted : 2018-10-30

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

AbbVie Corporation

ELUXADOLINE

Formnext Forum

Not Confirmed

AbbVie Corporation

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-03-14

Date Granted : 2013-12-24

ELUXADOLINE

Brand Name : VIBERZI

Patent Number : 2560047

Filing Date : 2005-03-14

Strength per Unit : 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-03-14

Date Granted : 2013-12-24

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

AbbVie Corporation

ELUXADOLINE

Formnext Forum

Not Confirmed

AbbVie Corporation

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-07-07

Date Granted : 2018-10-30

ELUXADOLINE

Brand Name : VIBERZI

Patent Number : 2695126

Filing Date : 2008-07-07

Strength per Unit : 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-07-07

Date Granted : 2018-10-30

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!